818 related articles for article (PubMed ID: 20338925)
1. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
2. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.
Deguchi Y; Andoh A; Inatomi O; Araki Y; Hata K; Tsujikawa T; Kitoh K; Fujiyama Y
Int J Mol Med; 2005 Oct; 16(4):605-8. PubMed ID: 16142393
[TBL] [Abstract][Full Text] [Related]
3. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
5. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
6. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.
Katada K; Yoshida N; Suzuki T; Okuda T; Mizushima K; Takagi T; Ichikawa H; Naito Y; Cepinskas G; Yoshikawa T
Inflamm Res; 2008 Feb; 57(2):84-91. PubMed ID: 18288458
[TBL] [Abstract][Full Text] [Related]
7. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
Punekar S; Zak S; Kalter VG; Dobransky L; Punekar I; Lawler JW; Gutierrez LS
Pathobiology; 2008; 75(1):9-21. PubMed ID: 18334835
[TBL] [Abstract][Full Text] [Related]
10. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
11. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
Ghia JE; Blennerhassett P; Kumar-Ondiveeran H; Verdu EF; Collins SM
Gastroenterology; 2006 Oct; 131(4):1122-30. PubMed ID: 17030182
[TBL] [Abstract][Full Text] [Related]
12. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
14. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
[TBL] [Abstract][Full Text] [Related]
15. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
16. Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers.
Zhao Z; Satsu H; Fujisawa M; Hori M; Ishimoto Y; Totsuka M; Nambu A; Kakuta S; Ozaki H; Shimizu M
Amino Acids; 2008 Jun; 35(1):217-24. PubMed ID: 17619120
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
18. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Katada K; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Watabe J; Yoshida N; Okanoue T; Yoshikawa T
J Nutr Biochem; 2006 Jun; 17(6):402-9. PubMed ID: 16214331
[TBL] [Abstract][Full Text] [Related]
19. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]